79 related articles for article (PubMed ID: 18590277)
21. A template-assembled model of the N-peptide helix bundle from HIV-1 Gp-41 with high affinity for C-peptide.
Xu W; Taylor JW
Chem Biol Drug Des; 2007 Oct; 70(4):319-28. PubMed ID: 17937777
[TBL] [Abstract][Full Text] [Related]
22. Single-chain protein mimetics of the N-terminal heptad-repeat region of gp41 with potential as anti-HIV-1 drugs.
Crespillo S; Cámara-Artigas A; Casares S; Morel B; Cobos ES; Mateo PL; Mouz N; Martin CE; Roger MG; El Habib R; Su B; Moog C; Conejero-Lara F
Proc Natl Acad Sci U S A; 2014 Dec; 111(51):18207-12. PubMed ID: 25489108
[TBL] [Abstract][Full Text] [Related]
23. Lipopeptides derived from HIV and SIV mimicking the prehairpin intermediate of gp41 on solid supported lipid bilayers.
Schuy S; Schäfer E; Yoder NC; Kumar K; Vogel R; Janshoff A
J Struct Biol; 2009 Oct; 168(1):125-36. PubMed ID: 19406246
[TBL] [Abstract][Full Text] [Related]
24. Coiled-coil surface presentation: an efficient HIV gp41 binding interface mimic.
Schnarr NA; Kennan AJ
J Am Chem Soc; 2004 Aug; 126(33):10260-1. PubMed ID: 15315435
[TBL] [Abstract][Full Text] [Related]
25. An amphiphilic conjugate approach toward the design and synthesis of betulinic acid-polyphenol conjugates as inhibitors of the HIV-1 gp41 fusion core formation.
Liu Y; Ke Z; Wu KY; Liu S; Chen WH; Jiang S; Jiang ZH
ChemMedChem; 2011 Sep; 6(9):1654-64. PubMed ID: 21688394
[TBL] [Abstract][Full Text] [Related]
26. A suite of modular fluorescence assays interrogate the human immunodeficiency virus glycoprotein-41 coiled coil and assist in determining binding mechanism of low molecular weight fusion inhibitors.
Gochin M
Assay Drug Dev Technol; 2012 Oct; 10(5):407-16. PubMed ID: 22897493
[TBL] [Abstract][Full Text] [Related]
27. Conformational flexibility of the conserved hydrophobic pocket of HIV-1 gp41. Implications for the discovery of small-molecule fusion inhibitors.
Cano-Muñoz M; Jurado S; Morel B; Conejero-Lara F
Int J Biol Macromol; 2021 Dec; 192():90-99. PubMed ID: 34619276
[TBL] [Abstract][Full Text] [Related]
28. Structure-based design of substituted biphenyl ethylene ethers as ligands binding in the hydrophobic pocket of gp41 and blocking the helical bundle formation.
Liu B; Joseph RW; Dorsey BD; Schiksnis RA; Northrop K; Bukhtiyarova M; Springman EB
Bioorg Med Chem Lett; 2009 Oct; 19(19):5693-7. PubMed ID: 19699090
[TBL] [Abstract][Full Text] [Related]
29. Sensing HIV related protein using epitope imprinted hydrophilic polymer coated quartz crystal microbalance.
Lu CH; Zhang Y; Tang SF; Fang ZB; Yang HH; Chen X; Chen GN
Biosens Bioelectron; 2012 Jan; 31(1):439-44. PubMed ID: 22143073
[TBL] [Abstract][Full Text] [Related]
30. Structural details of HIV-1 recognition by the broadly neutralizing monoclonal antibody 2F5: epitope conformation, antigen-recognition loop mobility, and anion-binding site.
Julien JP; Bryson S; Nieva JL; Pai EF
J Mol Biol; 2008 Dec; 384(2):377-92. PubMed ID: 18824005
[TBL] [Abstract][Full Text] [Related]
31. Design of improved protein inhibitors of HIV-1 cell entry: Optimization of electrostatic interactions at the binding interface.
Green DF; Tidor B
Proteins; 2005 Sep; 60(4):644-57. PubMed ID: 16001428
[TBL] [Abstract][Full Text] [Related]
32. Making strides in peptide-based therapeutics.
Guarracino DA; Arora PS
Chem Biol; 2009 Sep; 16(9):919-20. PubMed ID: 19778718
[TBL] [Abstract][Full Text] [Related]
33. Crystal structure of the complex between the F(ab)' fragment of the cross-neutralizing anti-HIV-1 antibody 2F5 and the F(ab) fragment of its anti-idiotypic antibody 3H6.
Bryson S; Julien JP; Isenman DE; Kunert R; Katinger H; Pai EF
J Mol Biol; 2008 Oct; 382(4):910-9. PubMed ID: 18692506
[TBL] [Abstract][Full Text] [Related]
34. [Chemokine receptors and its importance in the replication cycle of human immunodeficiency virus: clinical and therapeutic implications].
Azevedo-Pereira JM; Santos-Costa Q
Acta Med Port; 2008; 21(5):497-504. PubMed ID: 19187693
[TBL] [Abstract][Full Text] [Related]
35. Enhanced potency of bivalent small molecule gp41 inhibitors.
Sofiyev V; Kaur H; Snyder BA; Hogan PA; Ptak RG; Hwang P; Gochin M
Bioorg Med Chem; 2017 Jan; 25(1):408-420. PubMed ID: 27908751
[TBL] [Abstract][Full Text] [Related]
36. The application of perfluorooctanoate to investigate trimerization of the human immunodeficiency virus-1 gp41 ectodomain by electrophoresis.
Lin CH; Chang CC; Cheng SF; Chang DK
Electrophoresis; 2008 Aug; 29(15):3175-82. PubMed ID: 18633939
[TBL] [Abstract][Full Text] [Related]
37. Characterization of a trimeric MPER containing HIV-1 gp41 antigen.
Hinz A; Schoehn G; Quendler H; Hulsik DL; Stiegler G; Katinger H; Seaman MS; Montefiori D; Weissenhorn W
Virology; 2009 Aug; 390(2):221-7. PubMed ID: 19539967
[TBL] [Abstract][Full Text] [Related]
38. Hydrophobicity maps of the N-peptide coiled coil of HIV-1 gp41.
Siebert X; Hummer G
Biochemistry; 2002 Mar; 41(9):2956-61. PubMed ID: 11863433
[TBL] [Abstract][Full Text] [Related]
39. Amyloid-beta detection with saccharide immobilized gold nanoparticle on carbon electrode.
Chikae M; Fukuda T; Kerman K; Idegami K; Miura Y; Tamiya E
Bioelectrochemistry; 2008 Nov; 74(1):118-23. PubMed ID: 18676183
[TBL] [Abstract][Full Text] [Related]
40. NMR second site screening for structure determination of ligands bound in the hydrophobic pocket of HIV-1 gp41.
Balogh E; Wu D; Zhou G; Gochin M
J Am Chem Soc; 2009 Mar; 131(8):2821-3. PubMed ID: 19206471
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
